Development of Drugs That Target Prostate Cancer

Medicine & Life Sciences

1. Prostatic Neoplasms 100%
2. Sorafenib 89%
3. Drug Development 88%
4. Prostate-Specific Antigen 74%
5. Androgens 73%
6. Ketoconazole 59%
7. Docetaxel 35%
8. perifosine 27%
9. Progression-Free Survival 21%
10. Bone and Bones 14%
11. Computational Chemistry 14%
12. Fatigue 13%
13. Pharmaceutical Preparations 13%
14. Neoplasms 12%
15. Proto-Oncogene Proteins c-raf 12%
16. Hand-Foot Syndrome 11%
17. In Vitro Techniques 10%
18. Alendronate 10%
19. Hypertension 10%
20. Protein Array Analysis 10%
21. Vascular Endothelial Growth Factor Receptor-2 10%
22. Biopsy 9%
23. Neoplasm Grading 9%
24. Survival 8%
25. MAP Kinase Signaling System 8%
26. Anorexia 8%
27. Exanthema 8%
28. Biological Products 7%
29. Microtubules 7%
30. Proteomics 7%
31. Nausea 7%
32. Diarrhea 6%
33. Therapeutics 6%
34. Protein Isoforms 6%
35. Leukocytes 6%
36. Pharmacokinetics 6%
37. Bone Marrow 5%
38. Technology 5%
39. Clinical Trials 5%
40. Biomarkers 5%